Effect of Argatroban Plus Intravenous Alteplase vs Intravenous Alteplase Alone on Neurologic Function in Patients with Acute Ischemic Stroke: The ARAIS Randomized Clinical Trial
Previous studies suggested the benefit of argatroban plus alteplase (recombinant tissue-type plasminogen activator) in patients with acute ischemic stroke (AIS). However, strong evidence in trials with large sample sizes
Is there any association between serum asprosin levels and acute ischemic stroke?
Acute ischemic stroke constitutes a sequence of clinical syndromes of neurological dysfunction caused by the sudden interruption of the blood supply to the brain due to different reasons resulting in dysuria. Risk factors for ischemic stroke